Infinity Pharmaceuticals, Inc. INFI will host a conference call on Thursday, August 6, 2015, at 8:30 a.m. ET to review its second quarter 2015 financial results and provide an update on the company.
A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 72290673. An archived version of the webcast will be available on Infinity's website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company's website at www.infi.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150730005051/en/
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Senior
Investor Relations Associate,
Investor Relations and Corporate
Communications
Kate.Murray@infi.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.